ANVS Chart
- 52-Week Range: $8.81 - $120.97
- Market Capitalization: $76.90M
- Short Percentage: 0%
- Target Price: $31.50
- Shares Outstanding: 8.16M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Annovis Bio Announces First Quarter 2022 Results and Provides Corporate UpdateNewsfile Corp | May 4th
- Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022)Newsfile Corp | March 18th
- FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's DiseaseBenzinga | January 25th
- Annovis Bio Announces Official Unique Name Buntanetap for Lead Candidate ANVS401Newsfile Corp | January 5th
- Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual ConferencesNewsfile Corp | January 3rd
- Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed PharmaceuticsNewsfile Corp | December 14th
- Annovis Bio Presented At The 14th Clinical Trials on Alzheimer's Disease ConferenceNewsfile Corp | November 12th
- SHAREHOLDER ALERT: Robbins LLP Investigates Annovis Bio, Inc. (ANVS) for Misleading ShareholdersBusiness Wire | November 3rd
Company Info
Website: https://www.annovisbio.com
Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312
Sector: Healthcare
Industry: Biotechnology
Full time employees: 3
Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312
Sector: Healthcare
Industry: Biotechnology
Full time employees: 3
$ANVS I like it
$ANVS Beautiful!! 😀
$ANVS this stock has me so excited i cant sleep!!
$ANVS Longs will be rewarded handsomely
$ANVS almost go time
$ANVS I already know
tomorrow the bulls going to say "next week" just like every week.
$ANVS all in
$ANVS prepare your cash to buy dip
$ANVS man this will be good in coming weeks
$ANVS Another boring day I believe